Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, C. S.
Right arrow Articles by Calne, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, C. S.
Right arrow Articles by Calne, D. B.
NEUROLOGY 1995;45:435-439
© 1995 American Academy of Neurology

Patterns of Asymmetry Do Not Change Over the Course of Idiopathic Parkinsonism

Implications for Pathogenesis

C. S. Lee, MD, M. Schulzer, MD, E. Mak, BASc, J. P. Hammerstad, MD, S. Calne, RN and D. B. Calne, DM, FRCPC

Article abstract-We investigated the asymmetry of focal deficits of bradykinesia in a cross-sectional study of 198 patients with idiopathic parkinsonism. We have analyzed the difference in Unified Parkinson's Disease Rating Scale (UPDRS) scores between the more and less affected sides in these patients, whose duration of symptoms ranged from 1 to 15 years. There was no significant change in the asymmetry or focality over this period; the deficit for each side progressed faster initially and then approached the normal age-related linear rate of decline. Previous studies indicate that there is an inverse linear relation between the UPDRS bradykinesia score and the nigral dopaminergic cell count. We infer that the rate of death of nigral dopaminergic neurons is predetermined from the time of onset of pathogenesis. The simplest explanation is that a causal event kills some cells and damages others so that they undergo premature death. This sequence of changes could be implemented through environmental (toxic or viral) damage to the genome. Several diverse sources of evidence support this concept.

NEUROLOGY 1995;45: 435-439




This article has been cited by other articles:


Home page
 Arch NeurolHome page
C. S. Lee, M. Schulzer, R. de la Fuente-Fernandez, E. Mak, L. Kuramoto, V. Sossi, T. J. Ruth, D. B. Calne, and A. J. Stoessl
Lack of Regional Selectivity During the Progression of Parkinson Disease: Implications for Pathogenesis
Arch Neurol, December 1, 2004; 61(12): 1920 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R Tomer and J Aharon-Peretz
Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency
J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 972 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. Nicholson, A. C. Pereira, and G. M. Hall
Parkinson's disease and anaesthesia
Br. J. Anaesth., December 1, 2002; 89(6): 904 - 916.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. Hardy and K. Gwinn-Hardy
Genetic Classification of Primary Neurodegenerative Disease
Science, November 6, 1998; 282(5391): 1075 - 1079.
[Abstract] [Full Text]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S. S SHERGILL, Z. WALKER, and C. LE KATONA
A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis
J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 610 - 611.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.